Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
30.06M | 20.81M | 11.44M | 6.94M | 6.19M | Gross Profit |
2.92M | -700.70K | -1.45M | -1.06M | -180.79K | EBIT |
-828.82K | -1.60M | -2.88M | -3.65M | -1.87M | EBITDA |
-495.13K | -1.00M | -2.45M | -3.56M | -1.69M | Net Income Common Stockholders |
-932.86K | -1.54M | -2.79M | -3.81M | -1.91M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
850.43K | 1.94M | 2.39M | 4.21M | 1.98M | Total Assets |
5.71M | 5.91M | 6.58M | 4.86M | 3.26M | Total Debt |
1.35M | 302.08K | 521.13K | 71.52K | 2.42M | Net Debt |
498.27K | -1.64M | -1.87M | -4.13M | 439.21K | Total Liabilities |
4.91M | 4.67M | 4.01M | 1.25M | 4.43M | Stockholders Equity |
798.37K | 1.24M | 2.57M | 3.61M | -1.16M |
Cash Flow | Free Cash Flow | |||
-2.32M | -66.17K | -2.82M | -3.53M | -831.44K | Operating Cash Flow |
-2.21M | 28.20K | -2.47M | -3.50M | -814.65K | Investing Cash Flow |
-289.02K | -346.22K | -811.06K | -21.57K | -16.79K | Financing Cash Flow |
1.41M | -125.63K | 1.49M | 5.75M | 2.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | AU$623.76M | 95.25 | 11.59% | ― | 9.76% | -28.92% | |
67 Neutral | AU$215.47M | 1.35 | 257.93% | 0.90% | ― | ― | |
64 Neutral | $4.25B | 11.69 | 5.23% | 249.83% | 4.04% | -9.46% | |
55 Neutral | AU$8.09M | ― | -79.98% | ― | 19.94% | 58.99% | |
54 Neutral | AU$167.84M | ― | -28.12% | ― | -0.33% | -671.76% | |
36 Underperform | AU$14.31M | ― | -434.90% | ― | 72.45% | 47.70% |
Hiremii Limited has achieved a significant milestone by completing its 2024-25 product roadmap ahead of schedule, introducing a disruptive AI-first tech-recruitment solution. The company’s proprietary AI platform has outperformed industry benchmarks in candidate shortlisting accuracy and has been deployed for a global pharmaceutical client. Despite a slight decline in Q3 FY25 revenue due to a global slowdown, the market is showing signs of recovery, and the company maintains a stable gross profit margin.
Hiremii Limited reported a 5.6% increase in revenues for the half-year ending December 31, 2024, reaching $15,152,144. Despite this growth, the company experienced a reduced loss of $474,629, down 23.2% from the previous year. No dividends were declared during this period. The financial results indicate a positive trend in revenue growth, although the company continues to operate at a loss, reflecting ongoing challenges in achieving profitability.